Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-2,565
Closed -$234K 132
2023
Q4
$234K Sell
2,565
-110
-4% -$8.83K 0.08% 119
2023
Q3
$209K Sell
2,675
-321
-11% -$27.6K 0.08% 120
2023
Q2
$250K Sell
2,996
-4,870
-62% -$414K 0.09% 117
2023
Q1
$692K Sell
7,866
-60
-0.8% -$5.66K 0.26% 65
2022
Q4
$794K Sell
7,926
-17,936
-69% -$1.83M 0.3% 54
2022
Q3
$2.39M Buy
25,862
+16,192
+167% +$1.78M 0.32% 54
2022
Q2
$1.05M Sell
9,670
-119
-1% -$14.4K 0.4% 49
2022
Q1
$1.22M Buy
9,789
+60
+0.6% +$7.98K 0.4% 50
2021
Q4
$1.45M Hold
9,729
0.47% 44
2021
Q3
$1.43M Hold
9,729
0.52% 45
2021
Q2
$1.62M Sell
9,729
-78
-0.8% -$13K 0.58% 41
2021
Q1
$1.58M Hold
9,807
0.63% 40
2020
Q4
$1.43M Buy
9,807
+735
+8% +$104K 0.59% 44
2020
Q3
$1.21M Sell
9,072
-12
-0.1% -$1.61K 0.58% 43
2020
Q2
$1.19M Sell
9,084
-24
-0.3% -$3.02K 0.63% 43
2020
Q1
$1.04M Buy
9,108
+60
+0.7% +$7.89K 0.69% 40
2019
Q4
$1.33M Sell
9,048
-1,076
-11% -$151K 0.68% 39
2019
Q3
$1.39M Sell
10,124
-60
-0.6% -$8.39K 0.75% 39
2019
Q2
$1.48M Sell
10,184
-66
-0.6% -$10.2K 0.77% 38
2019
Q1
$1.78M Buy
10,250
+957
+10% +$161K 0.9% 38
2018
Q4
$1.48M Buy
+9,293
New +$1.54M 0.88% 40

Other funds holding MMM

O'Brien Greene & Co's MMM Position: Q1 2024 in Review

O'Brien Greene & Co sold out of 3M (MMM) in Q1 2024, closing a stake of 2,565 shares — an estimated $234K sold.

O'Brien Greene & Co first reported a position in MMM in Q4 2018 and held it in 21 quarters. The position peaked at $2.39M in Q3 2022. 1,939 funds tracked by Wall St. Rank hold MMM as of Q1 2024.

  • O'Brien Greene & Co reported no remaining 3M position as of Q1 2024 after selling out during the quarter.
  • O'Brien Greene & Co sold 2,565 3M shares in Q1 2024, an estimated $234K.
  • O'Brien Greene & Co first reported a position in 3M in Q4 2018 and held it in 21 quarters.
  • O'Brien Greene & Co's 3M position peaked at $2.39M in Q3 2022.
  • 1,939 funds tracked by Wall St. Rank held 3M as of Q1 2024.

Based on O'Brien Greene & Co's 13F filing for Q1 2024, filed 2 May 2024.